Contact Us

MEETING NEWS

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

Oct 20, 2024

GOTHENBURG,Sweden,Oct. 18,2024-- "The order intake increased by 10.0%,of which organic growth was 7.4%. All regions reported a positive performance," saysMattias Perjos,President & CEO a

Stay Better in China: Civilization is Colorful for Communication

Oct 20, 2024

NANCHANG,China,Oct. 18,2024-- A report from Jiangxi International Communication Center(JXICC):  

Power Supply Brings a Bumper Rice Harvest

Oct 20, 2024

ZIBO,China,Oct. 18,2024-- The harvest season brings the delightful scent of rice as blossoms in spring turn into fruitsin autumn. On October 15,the rice harvest in Gaoqing County,Zibo City,was in full

OURHOME to Showcase K-Food at 'SIAL Paris 2024'

Oct 20, 2024

Participating from October 19-23 in Paris to expand exports in the global market Showcasing K-Food,including kimchi,street food,and soups to attract local visitors and global buyers

Kroll Liquidators Secured Multi-Million Dollar Settlement Between Emergent Fidelity Technologies and FTX Estate Approved by US Bankruptcy Court

Oct 20, 2024

NEW YORK,Oct. 18,2024-- Kroll,the leading independent provider of global financial and risk advisory solutions,announced today that a multi-million dollar settlement between the liquidators of Emerge

LaNova Medicines Announces Initiation of Phase 1 Clinical Trial of Anti-PD-1/VEGF Bispecific Antibody LM-299 and Completion of $42 Million Series C1 Financing

Oct 20, 2024

Phase 1 trial of LM-299,an anti-PD-1/VEGF BsAb,initiated in China for advanced solid tumors following promising preclinical results demonstrating strong inhibition of tumor growth and well-tolerated s

1 ... 255 256 257 258 259 260 261 ... 341